For instance, classical Ly6Chi monocytes were proposed to predict response to anti-PD-1 immunotherapy47, and pro-angiogenic non-classical Ly6Clo monocytes were thought to contribute to resistance against anti-VEGF therapies in mouse models of colorectal cancer, and in human15,48. The gene discussed is VEGFA; the disease is colorectal cancer.